Clin2
NCT07480486Likely a fitNot yet recruiting

Personalized antidepressant selection using genetic testing

Depression - Major Depressive Disorder

Part of Mental health clinical trials.

This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
570 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with depression by a healthcare professional.
  • You are planning to start or change antidepressant medication.
  • You are able to understand the study and give written consent.
  • You are not currently pregnant or breastfeeding.
  • You are not taking medications that could interfere with the study drug.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07738497Not yet recruiting
Precision treatment for depression using biomarkers

This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.

NCT07373470Recruiting
Pharmacist help with depression meds using your DNA

This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.

Pittsburgh, Pennsylvania
NCT06729541Recruiting
Precision treatments for common mental disorders

This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.

Beijing, Beijing Municipality
NCT07680140Recruiting· Phase 4
Using biomarkers to choose depression treatment

This study uses a blood test (biomarker) to help pick the antidepressant that might work best for you. It compares two treatments—standard antidepressants and ketamine—in people with major depression who haven't gotten enough relief from one prior treatment.

New York, New York
NCT07810738Not yet recruiting· Phase 2
Computer-guided treatment selection for older adults with tough depression

This study tests a computer-based tool to help choose the next medication for older adults with stubborn depression. It may help match you with a treatment (aripiprazole or bupropion) that is more likely to work for you.

St Louis, Missouri
NCT04507555Recruiting
Pharmacist-guided genetic testing to choose antidepressants

This study tests whether doing genetic testing before starting or adjusting antidepressants—guided by a pharmacist—can improve treatment for people with moderate to severe depression. The goal is to help match you with antidepressants more safely and effectively.

Münchenbuchsee, Canton of Bern

Hear when a new Depression - Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.